Garda Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,400
Closed -$1.89M 250
2025
Q2
$1.89M Sell
12,400
-7,500
-38% -$1.15M 0.05% 282
2025
Q1
$3.3M Buy
+19,900
New +$3.11M 0.08% 263
2024
Q4
Sell
-38,900
Closed -$6.3M 356
2024
Q3
$6.3M Buy
38,900
+36,400
+1,456% +$5.8M 0.18% 164
2024
Q2
$365K Buy
+2,500
New +$372K 0.01% 424
2024
Q1
Sell
-13,000
Closed -$2.04M 498
2023
Q4
$2.04M Sell
13,000
-16,000
-55% -$2.45M 0.18% 138
2023
Q3
$4.52M Sell
29,000
-3,500
-11% -$578K 0.21% 88
2023
Q2
$5.38M Buy
32,500
+25,500
+364% +$4.12M 0.3% 75
2023
Q1
$1.08M Sell
7,000
-22,500
-76% -$3.63M 0.05% 232
2022
Q4
$5.21M Buy
+29,500
New +$5.09M 0.29% 107

Other funds holding JNJ

Garda Capital Partners's JNJ Position: Q3 2025 in Review

Garda Capital Partners sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 1,343 shares — an estimated $205K sold.

Garda Capital Partners first reported a position in JNJ in Q1 2023 and held it in 4 quarters. The position peaked at $1.79M in Q3 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Garda Capital Partners reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 1,343 Johnson & Johnson shares in Q3 2025, an estimated $205K.
  • Garda Capital Partners first reported a position in Johnson & Johnson in Q1 2023 and held it in 4 quarters.
  • Garda Capital Partners's Johnson & Johnson position peaked at $1.79M in Q3 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.